MyEG will be the sole distributor of the vaccine in Malaysia upon successful completion of the phase three trials, it said in a statement.
PETALING JAYA: My E.G. Services Bhd
has entered into a memorandum of understanding (MoU) with Anhui Zhifei Longcom Biopharmaceutical Co Ltd to conduct phase three clinical trials and subsequent commercialisation of its Covid-19 vaccine in Malaysia.
MyEG will be the sole distributor of the vaccine in Malaysia upon successful completion of the phase three trials, it said in a statement.
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
